METTL14 promotes SOCS2 expression to inhibit the progression of liver cancer,110 while METTL3 inhibits SOCS2 expression in a YTHDF2-dependent manner,137 but whether METTL3 regulates the metabolism of HCC through SOCS2 requires more direct evidence. Here, METTL14 is linked to hepatocellular carcinoma.